<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05012137</url>
  </required_header>
  <id_info>
    <org_study_id>SASIS-FICB</org_study_id>
    <nct_id>NCT05012137</nct_id>
  </id_info>
  <brief_title>The MEV of 0.5% Ropivacaine in Ultrasound-guided SASIS-FICB</brief_title>
  <acronym>SASIS-FICB</acronym>
  <official_title>The Minimum Effective Volume (MEV) of 0.5% Ropivacaine in Ultrasound-guided Supra-anterior Superior Iliac Spine Fascia Iliaca Compartment Block (SASIS-FICB)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Aim of This Study is to Determine the Minimum Effective Volume of Local Anesthetic&#xD;
      (Ropivacaine 0.5%) Required to Produce an Effective Ultrasound-guided Supra-anterior Superior&#xD;
      Iliac Spine Fascia Iliaca Compartment Block（SASIS-FICB） for Surgical Anesthesia in 90% of&#xD;
      Patients Scheduled for Elective Surgery of One Lower Limbs.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is based on biased coin design, and the volume of Local Anesthetic (Ropivacaine&#xD;
      0.5%) for the next patient is determined by the result of the last one. In the case of block&#xD;
      failure, the volume will be increased by 2.5ml. Conversely, block success will result in&#xD;
      either a reduction in volume by 2.5ml (probability 11%) or no change in volume (probability&#xD;
      89%). A blinded assistant will assess sensory and motor blockade in each nerve territory (&#xD;
      the femoral, obturator and lateral femoral cutaneous nerves) at 5-min intervals up to 30 min&#xD;
      after completion of the block. Finally, MEV90 is calculated by isotonic regression.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 25, 2021</start_date>
  <completion_date type="Anticipated">November 25, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 25, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>This is a dosing exploratory study.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The MEV90 of 0.5%Ropivacaine in Ultrasound-guided SASIS-FICBS</measure>
    <time_frame>up to 6 months</time_frame>
    <description>We prospectively recruited patients to receive different volumes of SASIS-FICB in accordance with the sequential trial rules of biased coins until 45 successful SASIS-FICB attempts were completed. MEV90 was calculated by isometric regression.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">54</enrollment>
  <condition>Nerve Block</condition>
  <arm_group>
    <arm_group_label>SASIS-FICB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects will be enrolled in the experimental group and receive an Ultrasound-guided Supra-anterior Superior Iliac Spine Fascia Iliaca Compartment Block (SASIS-FICB)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound-guided Supra-anterior Superior Iliac Spine Fascia Iliaca Compartment Block (SASIS-FICB) with 0.5% ropivacaine</intervention_name>
    <description>all the patients received Ultrasound-guided Supra-anterior Superior Iliac Spine Fascia Iliaca Compartment Block (SASIS-FICB)</description>
    <arm_group_label>SASIS-FICB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>different volume of 0.5% ropivacaine</intervention_name>
    <description>According to the subject's response to the injection dose, the next subject will be injected with a different volume of the drug according to the preset rules</description>
    <arm_group_label>SASIS-FICB</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients undergoing hip/knee surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age &lt;18 years&#xD;
&#xD;
          -  body mass index &gt;35&#xD;
&#xD;
          -  inability to consent to the study&#xD;
&#xD;
          -  allergy to local anesthetics&#xD;
&#xD;
          -  a history of liver or renal insufficiency, coagulopathy&#xD;
&#xD;
          -  clinical evidence of peripheral neuropathies, abnormalities of sensory or motor&#xD;
             function of the FN, ON or LFCN.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuguang Huang, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Director of Anesthesiology Department,Peking Union Medical College Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xulei Cui, MD</last_name>
    <phone>13717739381</phone>
    <email>cui.xulei@aliyun.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Xulei CUI, MD</last_name>
      <phone>+8613717739381</phone>
      <email>cui.xulei@aliyun.com</email>
    </contact>
    <contact_backup>
      <last_name>Yuguang Huang, MD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 12, 2021</study_first_submitted>
  <study_first_submitted_qc>August 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 19, 2021</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking Union Medical College Hospital</investigator_affiliation>
    <investigator_full_name>Cui Xulei</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Minimum Effective volume</keyword>
  <keyword>Ropivacaine</keyword>
  <keyword>Fascia Iliaca Compartment Block</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

